Novo Nordisk to Launch Tresiba Insulin Injection in India

Novo Nordisk is planning to launch its new once-daily Tresiba insulin injection for patients with both Type 1 and Type 2 diabetes in India by the end of 2013.
Pharmaceutical Business Review